San Diego, CA, March 2, 2022 - Speid & Associates is delighted to announce the return to the prestigious Harvard Club in Boston (public health conditions permitting), for the intensive, total immersion training in new medicine development, on 16 and 17 November 2022.
San Diego, CA, March 2, 2022 - Speid & Associates is delighted to announce the return to the prestigious Harvard Club in Boston (public health conditions permitting), for the intensive, total immersion training in new medicine development, on 16 and 17 November 2022.
The Harvard Club, at 374 Commonwealth Avenue, in Boston, has been a valued partner with the Drug Development Boot Camp® for eleven years. The Harvard Club enables the Faculty to provide an outstanding experience to the Participants, who are able to take the training face-to-face.
Dr. Lorna Speid, the Founder and Chair, is an expert in global regulatory affairs and new medicine development. She is joined by a world class Faculty of new medicine developers.
She said: “This is our thirteenth year providing this transformative training. Each year, we push our participants to their limits, so that they can go out and solve some very difficult challenges, in their own institutions.”
For more information about the Drug Development Boot Camp®, and to register, visit www.drugstomarket.com/drugbootcamp/
Dr. Speid can be contacted at Lspeid@sndtm.com or Tel: 858 793 1295.
Pharma companies and service companies that wish to sponsor the Drug Development Boot Camp® can contact Dr. Speid at the same contact number and email address.
About Speid & Associates, Inc. Speid & Associates, Inc. provides global and strategic regulatory affairs support for the development of new chemical and biological entities. It is a 100% woman owned business.